Presenilin 1 and presenilin 2 are widely expressed during brain development. Several mutations in these proteins have been associated with autosomal-dominant inherited forms of Alzheimer disease. Their expression is r...
This work was supported by the grants from the National Natural Science Foundation of China(No.31171019,No.81173108 and No.31000574);the Opening Projects of Shanghai Key Laboratory of Brain Functional Genomics and Key Laboratory of Brain Functional Genomics(East China Normal University),Ministry of Education.
Alzheimer’s disease(AD)is a common neurodegenerative disease characterized clinically by progressive deterioration of memory,and pathologically by histopathological changes including extracellular deposits of amyloid...
supported by the McKnight Neuroscience of Brain Disorders Award and NIH grant R01AG030746
Alzheimer disease(AD) is the most common neurodegenerative disorder worldwide and is at present,incurable.The accumulation of toxic amyloid-beta(Aβ) peptide aggregates in AD brain is thought to trigger the extensive ...
supported by the grants from Shanghai Science and Technology Commission (06DZ19003);National Natural Science Foundation of China (30870790);supported in part by 973 Project (2009CB918402)
Objective This report aims to describe the oxidative damage profile in brain ofpresenilinl andpresenilin2 conditional double knockout mice (dKO) at both early and late age stages, and to discuss the correlation betw...
Project supported by the State Key Technologies R & D Programme (973), No 1998051106.
AIM: To study the effects of presenilin-1 (PS-1), presenilin-2 (PS-2), and amyloid beta-protein precursor (APP695) on delayed rectifier potassium channels (IK) in the cultured rat hippocampal neurons. METHODS: PS-1, ...